The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Load More

ASCO 2022

American Society for Clinical Oncology Annual Meeting 2022
03–07 June 2022 | Chicago, IL, and Online
The 2022 ASCO Annual Meeting, held in Chicago, IL showcased the latest research in cancer care. This year's programme featured several sessions complementing the meeting's theme: Advancing Equitable Cancer Care Through Innovation. Key trial updates include the practice-changing results of DESTINY-Breast04, PARADIGM as well as the novel KRASG12C inhibitor adagrasib, in non-small cell lung cancer.
View all videos

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter